Trial Date Set In Bextra, Celebrex Case
A federal judge has set a spring date for the first product liability trials over Pfizer Inc.'s controversial anti-inflammatory drugs, Bextra and Celebrex....To view the full article, register now.
Already a subscriber? Click here to view full article